Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirtazapine for Methamphetamine Use Disorder Safety and DDI Study
NCT04614584Phase 1Completed
- Sponsor
- San Francisco Department of Public Health
- Start
- May 2021
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of mirtazapine in methamphetamine use disorder (MUD), sponsored by San Francisco Department of Public Health. Started May 2021; status: completed.
02
Drugs
mirtazapine
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT04614584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04614584.